Friday - July 18, 2025
Fox Chase Cancer Center Researcher Shows Biweekly Dose of TAS-102 Reduces Toxicity and Remains Effective for Treatment of Colorectal Cancer
June 05, 2025
PHILADELPHIA, Pennsylvania, June 5 [Category: Health Care] -- The Fox Chase Cancer Center, a part of Temple University Health System, posted the following news:

* * *

Fox Chase Cancer Center Researcher Shows Biweekly Dose of TAS-102 Reduces Toxicity and Remains Effective for Treatment of Colorectal Cancer

*

Christopher G. Cann, MD, Assistant Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center

PHILADELPHIA . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products